Free Trial
NYSE:BTX

Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis

Brooklyn ImmunoTherapeutics logo
$7.36 +0.07 (+0.96%)
As of 01:10 PM Eastern

About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX)

Key Stats

Today's Range
$7.29
$7.37
50-Day Range
$6.13
$7.44
52-Week Range
$5.10
$8.31
Volume
488,454 shs
Average Volume
751,620 shs
Market Capitalization
$432.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

BTX Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
'Brooklyn Nine-Nine' star Andre Braugher dies at 61
See More Headlines

BTX Stock Analysis - Frequently Asked Questions

Brooklyn ImmunoTherapeutics' stock was trading at $0.2940 at the beginning of 2025. Since then, BTX shares have increased by 2,406.8% and is now trading at $7.37.
View the best growth stocks for 2025 here
.

Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brooklyn ImmunoTherapeutics investors own include Mastech Digital (MHH), Altimeter Growth Corp. 2 (AGCB), African Gold Acquisition (AGAC), Aldel Financial (ADF), Adit EdTech Acquisition (ADEX) and Mega Matrix (ACY).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
Television Broadcasting
Sub-Industry
N/A
Current Symbol
NYSE:BTX
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$40.69 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$429.43 million
Optionable
No Data
Beta
4.61
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:BTX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners